Erratum to: Pain Ther DOI 10.1007/s40122-013-0010-2 {#Sec1}
===================================================

The author of the above-mentioned paper would like to make the following adjustment to her article.

In the last paragraph of the 'Current Treatments' section, the sentence currently reads 'Lidocaine/tetracaine cream (Pliaglis^®^, Galderma Laboratories, Texas, USA) is the first Food and Drug Administration (FDA)-approved stable compounded mixture of 7 % lidocaine and 7 % tetracaine cream.' This sentence should read 'Lidocaine/tetracaine cream (Pliaglis^®^, Galderma Laboratories, Texas, USA) is the first Food and Drug Administration (FDA)-approved stable eutectic mixture of 7 % lidocaine and 7 % tetracaine cream.'

This change has also been made to the article summary slide (available at: <http://www.paintherapy-open.com/>).

The author thanks Springer Healthcare for publishing the correction.

The online version of the original article can be found under doi:10.1007/s40122-013-0010-2.
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